Back to top
more

UCB (UCBJF)

(Delayed Data from OTC)

$165.75 USD

165.75
343

-3.04 (-1.80%)

Updated Aug 14, 2024 02:15 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (90 out of 250)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for UCBJF

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for UCB SA falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 1,193 1,336 1,817 1,880 1,631
Receivables 1,393 1,190 1,526 1,233 1,130
Notes Receivable 0 0 0 0 0
Inventories 1,116 956 1,039 976 874
Other Current Assets 26 0 7 3 56
Total Current Assets 3,727 3,481 4,389 4,092 3,690
Net Property & Equipment 1,726 1,511 1,508 1,182 941
Investments & Advances 227 230 238 183 196
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 870 797 819 691 978
Intangibles 10,267 10,700 9,858 9,066 6,606
Deposits & Other Assets 0 0 0 0 0
Total Assets 16,818 16,719 16,812 15,214 12,411
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 2,503 2,626 3,023 2,442 2,079
Current Portion Long-Term Debt 45 276 65 492 343
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 73 53 37 90 91
Other Current Liabilities 210 325 217 190 169
Total Current Liabilities 2,831 3,279 3,341 3,214 2,681
Mortgages 0 0 0 0 0
Deferred Taxes/Income 310 397 226 192 57
Convertible Debt 0 0 0 0 0
Long-Term Debt 3,243 2,779 2,447 2,646 1,092
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 721 713 877 856 730
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 7,104 7,169 6,890 6,907 4,561
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2,829 2,754 3,093 2,986 2,928
Capital Surplus 0 0 0 0 0
Retained Earnings 7,119 6,790 7,446 6,240 5,560
Other Equity 147 388 -150 -471 -215
Treasury Stock 382 382 467 449 422
Total Shareholder's Equity 9,714 9,550 9,921 8,307 7,850
Total Liabilities & Shareholder's Equity 16,818 16,719 16,812 15,214 12,411
Total Common Equity 9,714 9,550 9,921 8,307 7,850
Shares Outstanding NA 189.00 189.00 194.50 194.50
Book Value Per Share -0.10 50.53 52.49 42.71 40.36

Fiscal Year End for UCB SA falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents 742 -99,999 1,193 -99,999 818
Receivables 1,528 NA 1,393 NA 1,419
Notes Receivable NA NA 0 NA NA
Inventories 1,223 NA 1,116 NA 994
Other Current Assets 82 NA 26 NA 41
Total Current Assets 3,575 NA 3,727 NA 3,272
Net Property & Equipment 1,793 NA 1,726 NA 1,656
Investments & Advances 235 NA 227 NA 243
Other Non-Current Assets NA NA 0 NA NA
Deferred Charges 984 NA 870 NA 880
Intangibles 10,243 NA 10,267 NA 10,721
Deposits & Other Assets NA NA 0 NA NA
Total Assets 16,831 NA 16,818 NA 16,773
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA NA 0 NA NA
Accounts Payable 2,601 NA 2,503 NA 2,240
Current Portion Long-Term Debt 58 NA 45 NA 300
Current Portion Capital Leases NA NA 0 NA NA
Accrued Expenses NA NA 0 NA NA
Income Taxes Payable 110 NA 73 NA 128
Other Current Liabilities 244 NA 210 NA 220
Total Current Liabilities 3,013 NA 2,831 NA 2,887
Mortgages NA NA 0 NA NA
Deferred Taxes/Income 196 NA 310 NA 387
Convertible Debt NA NA 0 NA NA
Long-Term Debt 3,213 NA 3,243 NA 2,858
Non-Current Capital Leases NA NA 0 NA NA
Other Non-Current Liabilities 767 721 NA 781
Minority Interest (Liabilities) NA NA 0 NA NA
Total Liabilities 7,189 NA 7,104 NA 6,913
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA NA 0 NA NA
Common Stock (Par) 2,815 NA 2,829 NA 2,850
Capital Surplus NA NA 0 NA NA
Retained Earnings 6,991 NA 7,119 NA 7,072
Other Equity 276 NA 147 NA 328
Treasury Stock 440 NA 382 NA 390
Total Shareholder's Equity 9,641 NA 9,714 NA 9,859
Total Liabilities & Shareholder's Equity 16,831 NA 16,818 NA 16,773
Total Common Equity 109,640 0 9,714 0 109,858
Shares Outstanding NA NA NA NA NA
Book Value Per Share -1.10 0.00 -0.10 0.00 -1.10